These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [On the combined use of adonis vernalis with cardiac glycosides and strophanthin derivatives in treating patients with circulatory insufficiency]. Gubergrits AIa; Leshchinskiĭ LA Sov Med; 1968 Jan; 31(1):23-7. PubMed ID: 5691025 [No Abstract] [Full Text] [Related]
3. [Treatment of chronic circulatory insufficiency]. Li ED Feldsher Akush; 1980; 45(4):20-3. PubMed ID: 6899994 [No Abstract] [Full Text] [Related]
4. [Some pathogenetic characteristics of the development of circulatory insufficiency in the aged and the principles of treating it with cardiac glycosides]. Morozov KA; Slupskiĭ NN; Goriainova AN; Koriakin NN Ter Arkh; 1974; 46(12):25-33. PubMed ID: 4454017 [No Abstract] [Full Text] [Related]
7. [Clinical studies on the effect of Dezacetylolanatozide C (Polfa) in the treatment of heart diseases]. Wolański I; Grzywa M; Fijalkowska A Przegl Lek; 1969 Apr; 25(4):377-9. PubMed ID: 4892828 [No Abstract] [Full Text] [Related]
8. [The effect of certain cardiac glycosides on the zinc and copper level in the blood of arteriosclerotic patients with circulatory disorders]. Rachinskiĭ ID Sov Med; 1968 Nov; 31(11):136-8. PubMed ID: 5745411 [No Abstract] [Full Text] [Related]
9. [Rational use of cardiac glycosides in certain diseases in childhood]. Sidel'nikov VM; Afanas'ev EN; Liutkevich VF Pediatr Akus Ginekol; 1975; (3):3-6. PubMed ID: 1230764 [No Abstract] [Full Text] [Related]
10. [Reliability of cardiac glycoside administration under ambulatory conditions]. Kober R Dtsch Gesundheitsw; 1972 Jun; 27(23):1099-104. PubMed ID: 5078055 [No Abstract] [Full Text] [Related]
11. [The action of Teo-Caradrin in cardiovascular diseases. Our clinical experience]. Molino N; Belluardo C; Molino S Minerva Cardioangiol; 1969 Nov; 17(11):915-28. PubMed ID: 5404820 [No Abstract] [Full Text] [Related]
12. [Wolff-Parkinson-White syndrome. Electrocardiographic reason in false diagnosis of heart disease]. Westheim A; Erikssen J Nord Med; 1970 Jul; 84(31):973-8. PubMed ID: 5453092 [No Abstract] [Full Text] [Related]
13. [Treatment of patients with chronic ciruclatory insufficiency with erychroside]. Pocheptsov VG; Balaban EI Vrach Delo; 1967 Jun; 6():130-1. PubMed ID: 5602777 [No Abstract] [Full Text] [Related]
14. [Studies on the efficacy of cardiac glycosides in patients of a large old age home]. Iven A Med Monatsschr; 1966 Dec; 20(12):567-9. PubMed ID: 5980275 [No Abstract] [Full Text] [Related]
16. [Chronosensitivity to cardiac glycosides in patients with circulatory insufficiency in relation to the parameters of central and peripheral hemodynamics]. Zaslavskaia RM; Goncharov LF; Varshitskiĭ BG Klin Med (Mosk); 1990 Apr; 68(4):42-6. PubMed ID: 2370781 [No Abstract] [Full Text] [Related]
18. Prerenal uremia in chronic renal diseases. I. Prerenal uremia due to circulatory failure. Orlowski Z Pol Med J; 1969; 8(4):839-45. PubMed ID: 5404477 [No Abstract] [Full Text] [Related]
19. [Changes in electrocardiographic indices in children with circulatory disorders undergoing complex treatment using olitorizids]. Avdeeva GV Sov Zdravookhr Kirg; 1971; 3():23-5. PubMed ID: 5151499 [No Abstract] [Full Text] [Related]
20. [Unfavorable interactions of drugs after their combined use in cardiovascular pathology]. Eliseev OM; Novikova LS; Topolianskiĭ VD Ter Arkh; 1978; 50(1):109-22. PubMed ID: 345514 [No Abstract] [Full Text] [Related] [Next] [New Search]